Welcome to CDC stacks | GENOME EDITING IN HUMAN CELLS USING CRISPR/CAS NUCLEASES - 39220 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
GENOME EDITING IN HUMAN CELLS USING CRISPR/CAS NUCLEASES
Filetype[PDF-1.05 MB]


Details:
  • Pubmed ID:
    26423589
  • Pubmed Central ID:
    PMC4852847
  • Description:
    The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system has been broadly adopted for highly efficient genome editing in a variety of model organisms and human cell types. Unlike previous genome editing technologies such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), CRISPR/Cas technology does not require complex protein engineering and can be utilized by any researcher proficient in basic molecular biology and cell culture techniques. This unit describes protocols for design and cloning of vectors expressing single or multiplex gRNAs, for transient transfection of human cell lines, and for quantitation of mutation frequencies by T7 endonuclease I assay. These protocols also include guidance for using two improvements that increase the specificity of CRISPR/Cas nucleases: truncated gRNAs and dimeric RNA-guided FokI nucleases.

  • Document Type:
  • Collection(s):
  • Funding:
    DP1 GM105378/DP/NCCDPHP CDC HHS/United States
    DP1 GM105378/GM/NIGMS NIH HHS/United States
    F32 GM105189/GM/NIGMS NIH HHS/United States
    F32 GM105189/GM/NIGMS NIH HHS/United States
    P50 HG005550/HG/NHGRI NIH HHS/United States
    P50 HG005550/HG/NHGRI NIH HHS/United States
    R01 GM088040/GM/NIGMS NIH HHS/United States
    R01 GM088040/GM/NIGMS NIH HHS/United States
No Related Documents.
You May Also Like: